News

South East Asia Molecular Diagnostics Market Forecast to 2031: PCR Technology Leads Growth, Kits & Reagents Hold Largest Share
The Southeast Asia molecular diagnostics market is set to grow from USD 528.3 million in 2024 to USD 891.9 million by 2031, at a 7.8% CAGR. Key drivers include a rising elderly population, increased ...
You Can Soon Start Testing for HPV at Home — No Pap Required
The FDA has approved Teal Health's at-home test for HPV detection, which may help expand access to cervical cancer screening ...
Cervical cancer screening at home? US FDA approves kit. Why is this significant?
The US Food and Drug Administration (FDA) recently approved a first of its kind use-at-home cervical cancer screening tool.
Flow Space on MSN13h
UPDATE: Game-Changing At-Home HPV Test Finally Gets FDA Approval for Cervical Cancer Prevention
Update: The First Completely At-Home Cervical Cancer Test Has Officially Been FDA-Approved As of May 2025, the FDA has ...
KOBI-TV NBC5 / KOTI-TV NBC214h
FDA approves at home cervical cancer screening device
The FDA has approved the first at-home device for cervical cancer screening to test for HPV. HPV is the cause of nearly all ...
WGN Radio 72017h
FDA approves first ever at-home HPV test
Dr. Emma Barber, a gynecologic oncologist with the Lurie Cancer Center at Northwestern Medicine, joins Lisa Dent to discuss ...
MPR19h
FDA Clears Self-Collection Device for Cervical Cancer Screening
The Teal Wand is an at-home vaginal self-collection device intended to test for 14 types of high-risk HPV that have the ...
Clinical Advisor21h
FDA Approves At-Home Cervical Cancer Test for Women Ages 25 to 65
Teal Health has made an at-home test that screens for human papillomavirus (HPV), the virus that causes nearly all cervical cancers.
FDA approves first at-home cervical cancer detection device, offering new screening option
The first at-home device that can detect cervical cancer has been approved by the u-s food and drug administration.It allows ...